# A Disease Registry of Patients With Mantle Cell Lymphoma

> **NCT03816683** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 227 (actual)

## Conditions studied

- Mantle Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03816683
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2024-03-18
- **Final completion:** 2024-03-18
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03816683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03816683, "A Disease Registry of Patients With Mantle Cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03816683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*